⚕️FREE MSRA PODCAST –Primary Sclerosing Cholangitis
🎧 A clear, high-yield walkthrough of PSC, covering everything from pathophysiology and investigations tocomplications and screening – aligned with UK NICE guidance.
🧠Key Learning Points
📌Definition
• PSC is a chronic, progressive liver diseasecharacterised by inflammation and fibrosis ofthe bile ducts, leading to strictures,cholestasis, and liver damage.
📌Causes & RiskFactors
• Exact cause unknown, but likely due to geneticand immune factors.
• Strongly associated with Ulcerative Colitis(80% of PSC patients have UC).
• Typically affects men aged 30–60.
• Otherassociations: Crohn’s disease, HIV (rare).
📌Mnemonic for RiskProfile
🧍♂️ + 🧻 = PSC
(Young man +Ulcerative Colitis = Think PSC)
📌Pathophysiology
• Immune-mediated damage leads to chronicinflammation and fibrosis of bile ducts(intrahepatic and extrahepatic).
• Results in strictures, obstructed bile flow, andeventually cirrhosis or liver failure.
• Characteristic “beaded appearance” on imaging (MRCP).
📌DifferentialDiagnosis – VITAMIN B
• Vascular: Portal vein thrombosis
• Infective: Recurrent cholangitis, AIDS-related
• Trauma: Post-surgical bile duct injury
• Autoimmune: IgG4-related cholangitis,autoimmune hepatitis
• Malignancy: Cholangiocarcinoma
• Iatrogenic: Post-ERCP, TPN
• Benign: Gallstones
📌Epidemiology
• Rare, ~8–15 per100,000 in the UK
• 10% of liver transplants in the UK are due toPSC
• Median lifeexpectancy post-diagnosis ≈ 12 years
• Risk of cholangiocarcinoma and colorectal cancer (especially with UC)
📌Clinical Features
• Often asymptomatic early
• Symptoms: Fatigue, pruritus,jaundice, rightupper quadrant pain, weight loss
• Recurrent episodesof cholangitis (fever, pain, jaundice)
• Signs: Scratch marks, hepatomegaly,excoriations, signs of cirrhosis
📌Diagnosis
• Bloods: Raised ALP,GGT, sometimes bilirubin
• Autoantibodies: p-ANCA may be positive (notspecific)
• MRCP: Gold standard – shows beaded ducts
• ERCP: Diagnostic + therapeutic
• Liver biopsy: For staging or diagnosingsmall-duct PSC
📌Management
• No cure, treatment is symptomatic andpreventative
• Pruritus: Cholestyramine (1st line),rifampicin, naltrexone, SSRIs
• Nutrition: Supplement fat-soluble vitamins (A,D, E, K)
• Avoid alcohol, regular bone health monitoring
• ERCP for dominant strictures
• Liver transplant: Only definitive treatment foradvanced disease
• No routine use of UDCA – not proven to improveoutcomes
📌Complications
• Bile duct obstruction
• Recurrent cholangitis
• Liver cirrhosis and failure
• Cholangiocarcinoma
• Colorectal cancer (especially with UC)
• Hepatic osteodystrophy
📌Emergency – SuspectCholangitis
• Charcot’s triad: Fever + RUQ pain + Jaundice
• Treat urgentlywith IV antibiotics and ERCP drainage
📌Screening
• Annual colonoscopy if PSC + UC
• Gallbladder ultrasound to screen for polyps orcancer
• Monitor LFTs, bone health, and symptomsregularly
📎More MSRA Resourcesfor Primary Sclerosing Cholangitis
📝 Revision Notes:
https://www.passthemsra.com/topic/primary-sclerosing-cholangitis-revision-notes/
🧠 Flashcards:
https://www.passthemsra.com/topic/primary-sclerosing-cholangitis-flashcards/
💬 Accordion Q&A Notes:
https://www.passthemsra.com/topic/primary-sclerosing-cholangitis-accordion-qa-notes/
🚀 Rapid Quiz:
https://www.passthemsra.com/topic/primary-sclerosing-cholangitis-rapid-quiz/
🎓 Full Course:
https://www.passthemsra.com/courses/gastroenterology-for-the-msra/
Hashtags
#MSRA#MSRARevisionNotes #MSRAFlashcards #MSRAAccordions #MSRAQuestionBank #MSRAQuiz#PrimarySclerosingCholangitis #GastroenterologyMSRA #Cholangiocarcinoma#MRCPImaging #MSRAOnlineRevision